- Home
- AUTL vs IMSR Comparison
AUTL vs IMSR Comparison
Compare AUTL & IMSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AUTL | IMSR |
|---|---|---|
| Founded | 2014 | 2013 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 596.2M | 490.5M |
| IPO Year | 2025 | 2024 |
Fundamental Metrics
Financial Performance| Metric | AUTL | IMSR |
|---|---|---|
| Price | $1.89 | $4.30 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 1.1M |
| Earning Date | 05-14-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,120,000.00 | $248,357.00 |
| Revenue This Year | $80.32 | N/A |
| Revenue Next Year | $53.96 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 496.00 | N/A |
| 52 Week Low | $1.18 | $4.14 |
| 52 Week High | $2.58 | $16.38 |
Technical Indicators
Market Signals| Indicator | AUTL | IMSR |
|---|---|---|
| Relative Strength Index (RSI) | 40.65 | 39.72 |
| Support Level | $1.84 | $4.26 |
| Resistance Level | $1.92 | $5.69 |
| Average True Range (ATR) | 0.09 | 0.30 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 8.89 | 9.01 |
Price Performance
Historical ComparisonAbout AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8. Company's T cell programming technologies tailors therapies to address the specific disease targeting and introduce new programming modules into a patient's T cells to give those T cells improved properties to recognize target cells and overcome fundamental disease defense mechanisms.
About IMSR Terrestrial Energy Inc.
Terrestrial Energy Inc develops Generation IV nuclear power plants based on its proprietary Integral Molten Salt Reactor (IMSR) technology. Its small modular reactor plants are designed to provide low-carbon electricity and high-temperature industrial heat for applications including power generation, petrochemical and chemical processing, and data centers. The company is working with regulators, suppliers, industrial partners, and energy users to develop, license, and commission IMSR plants.